| 英文名稱 | Theralizumab | TGN1412 | TAB-08 | TABO8 |
|---|---|
| 中文名稱 | 西拉利珠單抗 |
| CAS號(hào) | 906068-56-2 |
| 儲(chǔ)存條件 | store at -20°C | Shipping with blue ice. |
| 規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專享價(jià) | 數(shù)量 |
|---|---|---|---|---|
| 1 mg | 3-5days | ¥3236.00 | 登錄后可見(jiàn) | |
| 5 mg | 3-5days | ¥8480.00 | 登錄后可見(jiàn) |
| 英文名稱 | Theralizumab | TGN1412 | TAB-08 | TABO8 |
|---|---|
| 中文名稱 | 西拉利珠單抗 |
| CAS號(hào) | 906068-56-2 |
| 儲(chǔ)存條件 | store at -20°C | Shipping with blue ice. |
Theralizumab (TGN1412) is a humanized lgG4 superagonistic anti-CD28 monoclonal antibody that directly stimulates T cells. Theralizumab can cause cytokine release syndrome (CRS). Theralizumab can be used for the research of rheumatoid arthritis.